Who Glioma

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma [Phase 2]

  A Phase 2 clinical trial update examining the combination of dabrafenib and trametinib after radiation therapy for newly diagnosed high-grad…

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) [Phase 2]

  Phase 2 study of tovorafenib for high-grade glioma with BRAF aberration and diffuse intrinsic pontine glioma; the trial is not yet recruitin…

• CLINICAL_TRIALS research · 2026-02-19
  Clinical Trial Update: Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations [Phase 2]

  This Clinical Trial Update reports on a Phase 2 study of olaparib in patients with advanced glioma, cholangiocarcinoma, or other IDH1/IDH2-m…

• CLINICAL_TRIALS trial_result · 2025-11-10
  Clinical Trial Update: Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma [NA]

  Mayo Clinic sponsors a clinical trial evaluating continuous glucose monitoring to manage hyperglycemia in patients with glioblastoma (IDH-wi…

• CLINICAL_TRIALS trial_result · 2025-07-11
  Clinical Trial Update: Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma [Phase 2]

  Phase 2 trial comparing proton beam therapy with intensity-modulated radiation therapy for preserving brain function in IDH-mutant grade II/…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-06-22
  Clinical Trial Update: Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy [Phase 4]

  Phase 4 trial assessing Perampanel for reducing seizure frequency in patients with high-grade glioma and focal epilepsy has been terminated …